AzTrials
AzTrials

Insomnia in PregnancyNCT04350333

Efficacy of Digital CBT-I Intervention During Pregnancy

A study testing CBT-I and Assertive communication training in people with Insomnia in Pregnancy, run by University of Rome G. Marconi.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This randomized controlled trial aims to evaluate the efficacy of Cognitive Behavioral Therapy for Insomnia in pregnant women. Particularly, this study aim to explore the effect of this intervention in ameliorating insomnia symptoms and in preventing post-partum depression disorder. Read more about this study

Who is it for?
Ages 19 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Insomnia in Pregnancy
What is being tested?
CBT-I and Assertive communication training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
114 participants
Where
No sites listed yet
Study dates
1 May 2021to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy pregnancy
  • Women that not consume nicotine or alcool
  • BMI < 30
  • Women who complains of insomnia or bad sleep quality

Who cannot join

  • BMI> 30
  • Complicated pregnancy
  • Women who consume nicotine or alcool

About this study

Official title: Efficacy of Digital Cognitive Behavioral Therapy for Insomnia (CBT-I) Intervention During Pregnancy in Prevention of Post-partum Depression: a Randomized Clinical Trial

This randomized controlled trial aims to evaluate the efficacy of Cognitive Behavioral Therapy for Insomnia in pregnant women. Particularly, this study aim to explore the effect of this intervention in ameliorating insomnia symptoms and in preventing post-partum depression disorder. The experimental intervention is a digital CBT-I and the control intervention group is an assertive communication training. Both interventions include a screening phase and will be delivered in a digital way and will be composed of 5 sessions. Furthermore, both interventions protocol include a baseline, half time and follow up assessments.

Being tested
CBT-I, Assertive communication training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CBT-IBehavioural

    Strategies and techniques of Cognitive behavioral therapy for insomnia adapted for pregnant women: stimulus control; sleep hygiene; sleep restriction; cognitive control etc.

  • Assertive communication trainingBehavioural

    Intervention based on improving assertive communication and regulating emotions.

Study groups in NCT04350333
Study groupRoleWhat they receive
CBT-I groupExperimentalFive sessions composed of: psychoeducation on sleep change during pregnancy and postpartum; sleep hygiene principles; stimulus control technique, sleep restriction technique (f this technique will be too difficult for the participants to be apply, a replacement and less disabling technique will be applied: sleep compression); psychoeducation on the child's sleep at birth and on the change in the sleep-wake cycle in the early stages of the child's life; cognitive control technique; cognitive reconstruction technique and de-catastrophization; relapses prevention.
Receives: Behavioral: CBT-I
Assertive communication trainingActive comparatorFive sessions composed of: psychoeducation and explanation of the importance of emotional and cognitive factors for good sleep. Psychoeducation about the concept of assertiveness, explanation of the passive, aggressive and assertive style; explanation and exercises regarding self-esteem and positive self-image; explanation of the development of sleep of the child in the first years of life; explanation and exercises on the phase of the management of feedback and requests; conflict management; relapses prevention.
Receives: Behavioral: Assertive communication training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression

    Depression symptomatology (Edinburgh Postnatal Depression Scale - EPDS). Scoring: < 8: depression not likely; 9-11: depression possible; 12-13:Fairly high possibility of depression; > 14 probable depression

    Measured: Follow up: 2 weeks post partum

  2. Depression

    Depression symptomatology (Edinburgh Postnatal Depression Scale - EPDS). Scoring: < 8: depression not likely; 9-11: depression possible; 12-13:Fairly high possibility of depression; > 14 probable depression

    Measured: Follow up: 3 months post partum

  3. Depression

    Depression symptomatology (Edinburgh Postnatal Depression Scale - EPDS). Scoring: < 8: depression not likely; 9-11: depression possible; 12-13:Fairly high possibility of depression; > 14 probable depression

    Measured: Follow up: 6 months post partum

  4. Anxiety

    Anxiety symptomatology (State-trait anxiety inventory - STAI-Y). Higher scores mean a worse outcome.

    Measured: Follow up: 2 weeks post partum

  5. Anxiety

    Anxiety symptomatology (State-trait anxiety inventory - STAI-Y). Higher scores mean a worse outcome.

    Measured: Follow up: 3 months post partum

  6. Anxiety

    Anxiety symptomatology (State-trait anxiety inventory - STAI-Y). Higher scores mean a worse outcome.

    Measured: Follow up: 6 months post partum

Secondary outcomes (3)
  1. Sleep pattern (sleep onset latency; total sleep time; wake after sleep onset; sleep efficiency)

    sleep pattern derived from sleep diaries

    Measured: Post intervention: after 5 weeks from the start of intervention

  2. insomnia symptoms

    Insomnia severity index scores (ISI). Scoring: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)

    Measured: Post intervention: after 5 weeks from the start of intervention

  3. Emotion regulation

    Emotion Regulation Questionnaire (ERQ) - Higher scores mean better outcome.

    Measured: Post intervention: after 5 weeks from the start of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2020
  2. Study start1 May 2021 (estimated)
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
114 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04350333
Sponsor's protocol ID
UMarconi
Status last verified
Apr 2021
First submitted
6 Apr 2020
Last updated
27 Apr 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing CBT-I and Assertive communication training in people with Insomnia in Pregnancy, run by University of Rome G. Marconi.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression (time frame: Follow up: 2 weeks post partum). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in